Net Cash Provided by (Used in) Financing Activities of HAEMONETICS CORP from 03 Apr 2010 to 28 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
HAEMONETICS CORP quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 03 Apr 2010 to 28 Jun 2025.
  • HAEMONETICS CORP Net Cash Provided by (Used in) Financing Activities for the quarter ending 28 Jun 2025 was $2,442,000, a 101% decline year-over-year.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Financing Activities for 2024 was $108,818,000, a 185% increase from 2023.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Financing Activities for 2023 was $38,157,000.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Financing Activities for 2022 was $100,364,000, a 537% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

HAEMONETICS CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,442,000 -$336,134,000 -101% 30 Mar 2025 28 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q2 2024 $333,692,000 +$334,290,000 31 Mar 2024 29 Jun 2024 10-Q 07 Aug 2025 2026 Q1
Q2 2023 $598,000 +$22,797,000 +97% 02 Apr 2023 01 Jul 2023 10-Q 08 Aug 2024 2025 Q1
Q2 2022 $23,395,000 -$21,761,000 -1332% 03 Apr 2022 02 Jul 2022 10-Q 08 Aug 2023 2024 Q1
Q2 2021 $1,634,000 -$150,585,000 -101% 04 Apr 2021 03 Jul 2021 10-Q 10 Aug 2022 2023 Q1
Q2 2020 $148,951,000 +$132,861,000 +826% 29 Mar 2020 27 Jun 2020 10-Q 11 Aug 2021 2022 Q1
Q2 2019 $16,090,000 -$2,573,000 -14% 31 Mar 2019 29 Jun 2019 10-Q 04 Aug 2020 2021 Q1
Q2 2018 $18,663,000 +$22,212,000 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2020 Q1
Q2 2017 $3,549,000 +$1,437,000 +29% 02 Apr 2017 01 Jul 2017 10-Q 07 Aug 2018 2019 Q1
Q2 2016 $4,986,000 +$24,786,000 +83% 03 Apr 2016 02 Jul 2016 10-Q 07 Aug 2017 2018 Q1
Q2 2015 $29,772,000 -$961,000 -3.3% 29 Mar 2015 27 Jun 2015 10-Q 01 Aug 2016 2017 Q1
Q2 2014 $28,811,000 -$38,315,000 -403% 30 Mar 2014 28 Jun 2014 10-Q 30 Jul 2015 2016 Q1
Q2 2013 $9,504,000 -$6,723,000 -41% 31 Mar 2013 29 Jun 2013 10-Q 31 Jul 2014 2015 Q1
Q2 2012 $16,227,000 +$11,760,000 +263% 01 Apr 2012 30 Jun 2012 10-Q 02 Aug 2013 2013 Q1
Q2 2011 $4,467,000 +$59,404,000 03 Apr 2011 02 Jul 2011 10-Q 08 Aug 2012 2012 Q1
Q2 2010 $54,937,000 04 Apr 2010 03 Jul 2010 10-Q 10 Aug 2011 2011 Q1

HAEMONETICS CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $108,818,000 +$70,661,000 +185% 31 Mar 2024 29 Mar 2025 10-K 21 May 2025 2025 FY
2023 $38,157,000 +$138,521,000 02 Apr 2023 30 Mar 2024 10-K 21 May 2025 2025 FY
2022 $100,364,000 -$84,615,000 -537% 03 Apr 2022 01 Apr 2023 10-K 21 May 2025 2025 FY
2021 $15,749,000 -$383,201,000 -104% 04 Apr 2021 02 Apr 2022 10-K 20 May 2024 2024 FY
2020 $367,452,000 +$498,660,000 29 Mar 2020 03 Apr 2021 10-K 22 May 2023 2023 FY
2019 $131,208,000 -$80,580,000 -159% 31 Mar 2019 28 Mar 2020 10-K 25 May 2022 2022 FY
2018 $50,628,000 +$70,015,000 +58% 01 Apr 2018 30 Mar 2019 10-K 26 May 2021 2021 FY
2017 $120,643,000 -$60,230,000 -100% 02 Apr 2017 31 Mar 2018 10-K 20 May 2020 2020 FY
2016 $60,413,000 +$2,211,000 +3.5% 03 Apr 2016 01 Apr 2017 10-K 22 May 2019 2019 FY
2015 $62,624,000 -$29,464,000 -89% 29 Mar 2015 02 Apr 2016 10-K 23 May 2018 2018 FY
2014 $33,160,000 -$12,461,000 -60% 30 Mar 2014 28 Mar 2015 10-K 24 May 2017 2017 FY
2013 $20,699,000 -$482,552,000 -104% 31 Mar 2013 29 Mar 2014 10-K 01 Jun 2016 2016 FY
2012 $461,853,000 +$492,323,000 01 Apr 2012 30 Mar 2013 10-K 22 May 2015 2015 FY
2011 $30,470,000 -$12,386,000 -68% 03 Apr 2011 31 Mar 2012 10-K 22 May 2014 2013 FY
2010 $18,084,000 -$4,114,000 -29% 04 Apr 2010 02 Apr 2011 10-K 20 May 2013 2012 FY
2009 $13,970,000 29 Mar 2009 03 Apr 2010 10-K 22 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.